Healio43m
Risks of ending disease-modifying therapy may be ‘minimal’ in older, stable adults with MS
It may be sensible for older patients with MS who have prolonged stability to cease disease-modifying therapy, but more data ...
Rolling Out6h
What no one tells you about sexually transmitted infections
Explore how sexually transmitted infections progress, symptoms to watch for, and prevention strategies to protect sexual ...
The American Journal of Managed Care7h
5 Rare Diseases That Now Have Their First FDA-Approved Treatments
Several rare disease patient populations received their first-ever FDA-approved drug since Rare Disease Day last year, ...
BioSpace11h
6 Rare Diseases That Have New FDA-Approved Treatments
ITF, IntraBio and Orchard are among the companies that have won FDA nods in the past year for Duchenne muscular dystrophy, ...
Treatment for a disease so rare, it has no name
The nameless disease is neurodegenerative, which means it has no cure, and Ireland could face a gradual decline in her ...
Why pharma is still far from a treatment for galactosemia
With issues in therapy delivery and a barren trial landscape, short-term chances for a commercial galactosemia treatment are ...
Medindia17h
Nasal Spray Offers New Hope for Brain Injury Treatment
Discover how a novel nasal spray could revolutionize traumatic brain injury treatment by reducing neuroinflammation and ...
'It's an everyday thing': Omaha woman discovers rare disease through social media
Could a social media post really solve years of confusion? Friedrich's Ataxia is a rare disease that only affects 1-in-50,000 people. "Looking at the way this girl moved — the unsteadiness and ...
Busting myths and misconceptions surrounding epilepsy
Epilepsy, a misunderstood neurological disorder, affects millions worldwide, but with proper treatment, individuals can lead ...